Serial 87678921

Dead / Cancelled — Cancelled — Section 8 (as of 14 Nov 2025)

What this means for you

This registration has been cancelled; it no longer blocks anyone on its own. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.

Record

Serial number
87678921
Registration number
5740764
Mark type
Design / logo
Filed
09 Nov 2017
Published for opposition
20 Feb 2018
Registered
30 Apr 2019
Attorney of record
Brian Focarino

Goods and services

  • Class 005 — Pharmaceuticals: Pharmaceutical preparations and human therapeutic preparations for treating and preventing amyloidosis, genetic diseases, disorders and conditions, and protein diseases, disorders and conditions; pharmaceutical preparations and human therapeutic preparations for treating neuropathy, neurological dysfunction, and damage to nerves, tissue, organs, intestinal tract, or bone marrow; pharmaceutical preparations and human therapeutic preparations, namely, injectable antisense drugs for reducing production of transthyretin

Owner

Prosecution history

  • 14 Nov 2025 — CANCELLED SEC. 8 (6-YR)
  • 25 Sept 2024 — TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
  • 25 Sept 2024 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
  • 25 Sept 2024 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
  • 25 Sept 2024 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
  • 25 Sept 2024 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
  • 25 Sept 2024 — TEAS CHANGE OF OWNER ADDRESS RECEIVED
  • 30 Apr 2024 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
  • 29 Jul 2020 — AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
  • 30 Apr 2019 — REGISTERED-PRINCIPAL REGISTER
  • 29 Mar 2019 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
  • 29 Mar 2019 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
  • 28 Mar 2019 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
  • 28 Mar 2019 — STATEMENT OF USE PROCESSING COMPLETE
  • 24 Mar 2019 — USE AMENDMENT FILED

View this trademark record on Marksy